Astrazeneca AZN Income Statement (2009-2026)

NYSE AZN
$160.15 +0.51 (+0.32%)
As of: Sep 11, 2026 · 3:59 PM EDT
Reported Financials

Astrazeneca Quarterly Income Statement

Periods 70 quarters
Latest Jun 2026

Astrazeneca reported revenue of $15.38B and net income of $2.51B for the quarter ended Jun 2026, up 6.5% year over year. This income statement covers 70 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
9.74B11.50B11.39B10.63B10.98B11.21B10.57B10.88B11.02B32.47B12.63B12.93B13.51B14.08B13.51B14.45B15.18B15.50B15.21B15.38B
Cost of RevenueCost of Rev
3.76B4.62B3.51B3.00B2.98B2.90B1.91B1.96B2.10B5.96B2.22B2.18B3.08B2.73B2.24B2.47B2.80B10.63B2.68B2.52B
Gross Profit
6.11B7.39B7.88B7.77B8.00B8.31B8.97B9.46B9.40B27.83B10.46B10.76B10.48B12.17B11.35B11.98B12.39B12.38B12.61B12.86B
Operating items
Research & DevelopmentR&D
-3.61B-2.58B-2.13B-2.55B-2.46B-2.62B-2.61B-2.67B-2.58B-3.07B-2.78B-3.01B-3.12B-4.68B-3.16B-3.55B-3.66B-14.23B-3.49B-4.05B
Selling, General & AdministrativeSG&A
-4.09B-5.12B-4.84B-4.68B-4.28B-4.62B-4.06B-4.99B-4.80B-5.37B-4.50B-4.93B-5.14B-5.41B-4.49B-4.86B-5.08B-19.93B-4.92B-5.65B
Other Operating ExpensesOther Opex
0.04B0.15B0.10B0.12B0.11B0.19B0.38B0.78B0.07B1.23B0.07B0.06B0.03B0.10B0.11B0.08B0.09B0.39B0.19B0.15B
Operating ExpensesOpex
-7.70B-7.70B-7.10B-7.23B-6.74B-7.25B-6.67B-7.65B-7.38B-8.44B-7.28B-7.94B-8.26B-10.09B-7.65B-8.41B-8.75B-34.16B-8.41B-9.70B
Operating IncomeOp. Inc
-1.67B-0.29B0.88B0.54B1.25B2.66B2.55B2.46B1.95B6.96B3.12B2.75B2.11B2.04B3.67B3.51B3.58B2.98B4.25B3.16B
EBIT
-1.67B-0.29B0.88B0.54B1.25B2.66B2.55B2.46B1.95B6.96B3.12B2.75B2.11B2.04B3.67B3.51B3.58B2.98B4.25B3.16B
Non-operating items
Non Operating Interest Expenses
-0.34B-0.34B-0.34B-0.31B-0.34B-0.36B-0.36B-0.43B-0.39B-0.94B-0.41B-0.44B-0.46B-0.43B-0.35B-0.44B-0.43B-1.70B-0.39B-0.43B
Non Operating Investment IncomeNon-Op. Investment Inc.
Interest & Investment IncomeInt & Inv Inc
0.01B0.00B0.02B0.02B0.01B0.04B0.08B0.06B0.10B0.11B0.11B0.10B0.18B0.06B0.08B0.07B0.09B0.14B0.07B0.08B
Other Non Operating IncomeOther Non Op Inc.
-3.61B-2.13B-2.46B-2.61B-2.58B-7.86B-2.78B-3.12B-3.16B-3.49B
Net income details
EBT
-2.00B-0.64B0.55B0.25B0.92B0.78B2.26B2.09B1.65B6.00B2.80B2.40B1.83B1.67B3.40B3.13B3.24B14.10B3.91B2.80B
Tax ProvisionsTaxes
0.35B0.29B-0.17B0.11B0.72B0.12B-0.46B-0.27B-0.27B-1.00B-0.62B-0.47B-0.40B-0.17B-0.48B-0.68B-0.71B-0.00B-0.83B-0.29B
Profit After TaxPAT
-1.98B-0.75B0.39B0.36B1.64B0.90B1.80B1.82B1.38B5.00B2.18B1.93B1.43B1.50B2.92B2.45B2.54B2.33B3.08B2.51B
Equity Income
-0.01B-0.78B-0.01B0.00B0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B0.01B-0.01B-0.01B-0.01B
Income from Non-Controlling InterestsInc. Minority
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B0.01B-0.00B0.00B-0.82B0.00B0.00B
Income from Continuing OperationsIncome (Continuing)
-2.35B-0.93B0.72B0.13B0.20B0.65B2.72B2.36B1.93B7.00B3.42B2.87B2.22B1.83B3.88B3.81B3.95B14.10B4.75B3.09B
Consolidated Net IncomeConsol Net Inc.
-2.35B-0.93B0.72B0.13B0.20B0.65B2.72B2.36B1.93B7.00B3.42B2.87B2.22B1.83B3.88B3.81B3.95B14.10B4.75B3.09B
Income towards Parent CompanyParent Net Inc
-1.65B-0.35B0.39B0.36B1.64B0.90B1.80B1.82B1.37B0.96B2.18B1.93B1.43B1.50B2.92B2.45B2.53B2.33B3.08B2.51B
Net Income towards Common StockholdersNet Income
-0.33B-0.40B0.39B0.36B1.64B0.90B1.80B1.82B1.37B0.96B2.18B1.93B1.43B1.50B2.92B2.45B2.53B2.33B3.08B2.51B
Additional items
EPS (Basic)
-0.25-0.280.270.251.160.581.161.170.890.621.411.240.920.971.881.581.631.501.991.62
EPS (Diluted)
-0.25-0.280.270.251.150.581.161.170.880.611.401.230.910.961.871.571.621.491.971.60
Shares Outstanding
1.31B1.42B1.42B1.42B1.42B1.55B1.55B1.55B1.55B1.55B1.55B1.55B1.55B1.55B1.55B1.55B1.55B1.55B1.55B1.55B
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
1.31B1.43B1.43B1.43B1.43B1.56B1.56B1.56B1.56B1.56B1.56B1.56B1.56B1.56B1.56B1.56B1.56B1.56B1.56B1.56B
Shares Outstanding (Entity)Shares Outstanding (Entity.)
1.55B1.55B1.55B1.55B1.55B
EBITDA
-1.67B-0.29B0.88B0.54B1.25B2.66B2.55B2.46B1.95B6.96B3.12B2.75B2.11B2.04B3.67B3.51B3.58B2.98B4.25B3.16B
Interest ExpensesInt Expense
-0.34B-0.34B-0.34B-0.31B-0.34B-0.36B-0.36B-0.43B-0.39B-0.94B-0.41B-0.44B-0.46B-0.43B-0.35B-0.44B-0.43B-1.70B-0.39B-0.43B
Tax Rate
-17.49%-45.60%-29.84%45.75%78.09%15.94%-20.25%-12.84%-16.59%-16.66%-22.14%-19.57%-21.61%-9.96%-14.14%-21.71%-21.86%-0.02%-21.28%-10.40%